Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  136,806 results for ""Bone Density""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level.

  • Authors : Chavassieux P; INSERM UMR 1033, UFR de Médecine Lyon-Est-Domaine Laennec, 7-11, Rue Guillaume Paradin, University de Lyon, 69372 Cedex 08, Lyon, France. .; Roux JP

Subjects: Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/pathology ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology

  • Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty.

  • Authors : Ueno M; Department of Orthopaedic Surgery, Machida Keisen Hospital, 2-1-47 Minamimachida, Machida, Tokyo, 194-0005, Japan. .; Tajima Y

Subjects: Kyphoplasty* ; Anabolic Agents*/Anabolic Agents*/Anabolic Agents*/pharmacology ; Anabolic Agents*/Anabolic Agents*/Anabolic Agents*/therapeutic use

  • Source: Archives of osteoporosis [Arch Osteoporos] 2024 Mar 21; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Mar 21.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

Record details

Read More Add to Saved list
×
Academic Journal

Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment.

  • Authors : Keum BR; Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Korea.; Research Center for drug development, CYPHARMA Co., Ltd., Daejeon 34133, Korea.

Subjects: Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/genetics ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Feb 20; Vol. 121 (8), pp. e2316871121. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactation-Associated Osteoporosis: A Systematic Review and Meta-analysis.

  • Authors : Anagnostis P; Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki 56403, Greece.; Lampropoulou-Adamidou K

Subjects: Osteoporosis*/Osteoporosis*/Osteoporosis*/therapy ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Feb 20; Vol. 109 (3), pp. 879-901.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Optimising zoledronate treatment holiday duration without loss of fracture prevention.

  • Authors : Drake MT; Division of Endocrinology, Diabetes and Metabolism and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: .

Subjects: Fractures, Bone*/Fractures, Bone*/Fractures, Bone*/prevention & control ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use; Humans

  • Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Apr; Vol. 12 (4), pp. 217-219. Date of Electronic Publication: 2024 Mar 04.Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years.

  • Authors : Reid IR; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: .; Horne AM

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Fractures, Bone*/Fractures, Bone*/Fractures, Bone*/epidemiology ; Fractures, Bone*/Fractures, Bone*/Fractures, Bone*/prevention & control

  • Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Apr; Vol. 12 (4), pp. 247-256. Date of Electronic Publication: 2024 Mar 04.Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Denosumab in the treatment of osteoporosis associated with chronic kidney disease.

  • Authors : Covic A; Department of Nephrology and Internal Medicine, Grigore T Popa University of Medicine and Pharmacy, Iași 700115, Romania. Electronic address: .; Apetrii M

Subjects: Osteoporosis*/Osteoporosis*/Osteoporosis*/complications ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Apr; Vol. 12 (4), pp. 225-227. Date of Electronic Publication: 2024 Feb 16.Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sustained hypophosphatemia after denosumab in a patient on hemodialysis.

  • Authors : Almodares AAS; Department of Medicine 1 - Endocrinology- Nephrology and Cardiology, Holbæk Hospital, Holbæk, Denmark.; Elder GJ

Subjects: Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/chemically induced ; Hypophosphatemia*/Hypophosphatemia*/Hypophosphatemia*/chemically induced ; Renal Insufficiency*/Renal Insufficiency*/Renal Insufficiency*/chemically induced

  • Source: Bone [Bone] 2024 Apr; Vol. 181, pp. 117045. Date of Electronic Publication: 2024 Feb 08.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Five-Year Outcomes of Continuous Treatment with Zoledronic Acid Versus Denosumab in Older Men with High Fracture Risk: Risk Factor Analysis of Bone Density Improvement and Incidence of New Fracture.

  • Authors : Wu TC; School of Medicine, Tzu Chi University, Hualien, Taiwan.; Department of Clinical Education, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporotic Fractures* ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Apr; Vol. 64 (4), pp. 469-477. Date of Electronic Publication: 2023 Nov 16.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
Academic Journal

Associations of Changes in Bone Turnover Markers with Change in Bone Mineral Density in Kidney Transplant Patients.

  • Authors : Jørgensen HS; Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium.; Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark.

Subjects: Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Bone Density Conservation Agents* ; Bone Diseases, Metabolic*

  • Source: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 Apr 01; Vol. 19 (4), pp. 483-493. Date of Electronic Publication: 2023 Nov 29.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  136,806 results for ""Bone Density""